Anaesthesia
Conditions
Interventions
NTI following FROVA catheter insertion
NTI from the beginning.
Sponsors
Dr Tarek Ismail
Dr Rabab S. Mahrous
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A randomized controlled clinical trial will be conducted. Adult patients with American Society of Anesthesiologists (ASA) physical status class I or II will be eligible for this study.
Exclusion criteria
Exclusion criteria: Patients with a history of known deformities of the nasal cavity, nasal surgery, trauma, recurrent epistaxis, blood dyscrasias, or coagulopathy, history of fracture or operation of the cranial base will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| •The procedure time (seconds) will be recorded from insertion of the of the FROVA catheter and or tracheal tube into the nostril to the time when capnography became evident on the monitor | — |
Secondary
| Measure | Time frame |
|---|---|
| • Incidence and severity of nasal bleeding will be evaluated by direct inspection of the mouth and pharynx using the laryngoscope, The severity of nasal bleeding will be graded using a four-point scale: no epistaxis; mild epistaxis (blood on the tracheal tube only or tinged on the posterior pharyngeal wall); moderate epistaxis (blood pooling in the pharynx); or severe epistaxis (blood in the pharynx sufficient to impede intubation and necessitating urgent orotracheal intubation | — |
Countries
Egypt
Contacts
Public ContactAmal Mohamed
Secretary of Research and opinion in Anesthesia and intensive care Journal
Outcome results
None listed